AKI India Q3 FY26: Standalone Woes Mask Consolidated Gains, Reporting Questions Arise

AKI India Limited's board meeting on February 12, 2026, approved financial results for Q3 and the first nine months of FY26, presenting a mixed and complex picture for investors. The company reported a significant divergence between its standalone and consolidated financials, coupled with reporting practices that warrant investor scrutiny.

📉 The Financial Deep Dive

Standalone Performance:
The standalone segment painted a grim picture, with Net Sales/Income from Operations for Q3 FY26 plummeting 39% year-on-year (YoY) to ₹1329.50 Cr from ₹2174.81 Cr in Q3 FY25. Profit Before Tax (PBT) saw a sharper decline of 70.5% to ₹29.71 Cr, leading to a 71.7% drop in Profit After Tax (PAT) to ₹18.93 Cr. Consequently, Earnings Per Share (EPS) fell to ₹0.02 from ₹0.08 YoY. For the nine-month period ended December 31, 2025, standalone revenue contracted 16.6% YoY to ₹4303.87 Cr, and PAT decreased by 47.3% YoY to ₹86.01 Cr.

Consolidated Performance:
In contrast, the consolidated results showcased robust growth. Consolidated Net Sales increased by 13.1% YoY to ₹2556.10 Cr in Q3 FY26. Consolidated PBT rose 13.9% YoY to ₹120.52 Cr, and consolidated PAT surged by a significant 51.6% YoY to ₹109.01 Cr. Diluted EPS for the quarter stood at ₹0.11, up from ₹0.08 YoY. The nine-month consolidated revenue grew 24.2% YoY to ₹7074.88 Cr, with PAT up 25.2% YoY to ₹210.00 Cr. This strong consolidated performance was aided by a substantial increase in 'Other Income' and contributions from associates and joint ventures.

Income Statement Drivers & Anomalies:
The core narrative is the stark dichotomy between the domestic business's decline and the international/group's growth. A notable observation is the reporting of 'Exceptional Items' amounting to ₹82.64 Cr for Q3 FY26. However, the reported PBT figures (₹29.71 Cr standalone, ₹120.52 Cr consolidated) appear to be derived before the direct adjustment of these exceptional items, a treatment that deviates from standard accounting practices and raises transparency questions.

Balance Sheet Impact:
The paid-up equity share capital saw an increase from ₹1770.64 Cr to ₹2064.12 Cr YoY on both standalone and consolidated bases. This suggests a capital infusion into the company, the purpose and implications of which are not detailed.

Auditor's Notes:
The limited review report by statutory auditors highlighted that interim financial results of AKI UK LIMITED were not reviewed by their auditors but were deemed immaterial by management. Results for AKI CASTIL SHOES LLP were reviewed by other auditors, with conclusions based on their findings. This reliance on external reviews and management's materiality assessment for subsidiaries could obscure underlying risks.

Lack of Guidance:
Crucially, no forward-looking management guidance or outlook was provided in the announcement, leaving investors without a clear roadmap for future performance.

🚩 Risks & Outlook

The primary risks revolve around the opacity of the reporting treatment for exceptional items, the sustainability of consolidated growth amidst standalone weakness, and the implications of the capital infusion. The reliance on reviewed, rather than audited, subsidiary results also adds a layer of uncertainty. Investors should closely monitor the company's subsequent disclosures and management commentary for clarity on these points.